Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company
focused on delivering innovative therapies to patients with kidney
disease through the biology of hypoxia inducible factor (HIF), today
announced financial results for the third quarter ended September 30,
Nuveen Investments, a leading global provider of investment services to
institutions as well as individual investors, today announced that the
reorganization of four Nuveen New Jersey closed-end funds was completed
prior to the opening of the New York Stock Exchange on November 10,
NICE is recognized for its product innovation for the third time by Public Safety Communications Magazine RA'ANANA, Israel , November 10, 2014 /PRNewswire/ --
NICE Systems (NASDAQ: NICE) today announced that the NICE Screen Logger was recognized as a 2014 Hot Product by Public Safety Communications , the official magazine of the Association of Public Safety Communications Officials (APCO) International.
BioLineRx (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage
biopharmaceutical company dedicated to identifying, in-licensing and
developing promising therapeutic candidates, today reported its
financial results for the third quarter ended September 30, 2014.
Record GAAP revenue of $44.3 million, up 10% from a year ago and non-GAAP revenue of $44.9 million GAAP net income of $0.2 million, EPS $0.01, non-GAAP net income of $1.0 million, and non-GAAP EPS of $0.07
MIDDLETOWN, R.I., Nov.
By Barbara Kollmeyer, MarketWatch
MADRID (MarketWatch) -- Stock futures pointed to a slightly higher start for Wall Street on Monday as oil prices rose and investors focused on whether the S&P 500 and Dow industrials can maintain recent record highs.
Technology (BTL), which specialises in online backup & disaster
recovery services for global enterprises, is helping Essex County Fire &
Rescue Service (ECFRS) safeguard the data it generates as it protects
local people and property.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.